GBMS yields 200000000.00% · PFE yields 6.20%● Live data
📍 GBMS pulled ahead of the other in Year 1
Combined, GBMS + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GBMS + PFE for your $10,000?
Global Materials & Services, Inc., a fire protection company, specializes in fire prevention and fire containment. It develops, manufactures, and markets a line of interior and exterior fire retardant chemicals and products; and provides fire resistive finishing services, through its textile processing center for commercial users. The company also designs new technology for future fire resistive applications that are being mandated by local, state, and governmental agencies. In addition, Global Materials & Services offers retails products, which include 3-in-1 Hero, a product for upholstery, draperies, carpets, and various fabrics to make them fire retardant and inhibit microorganisms, such as dust mites; and TreeSafe, a product that prevents flames from occurring or spreading on Christmas trees. The company was organized in 1992. It was formerly known as American Fire Retardant Corporation and changed its name to Global Materials & Services, Inc. in January 2005. Global Materials & Services is headquartered in Santee, California.
Full GBMS Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.